Moreover, efflux transporters, such as Breast Cancer Resistance Protein, BCRP, also known as ABCG2, can expel nucleoside analogs from cancer cells, which decreases their intracellular levels, thus contributing to resistance. The gene discussed is ABCG2; the disease is cancer.